1. TERT promoter mutation and its interaction with IDH mutations in glioma: Combined TERT promoter and IDH mutations stratifies lower-grade glioma into distinct survival subgroups—A meta-analysis of aggregate data 
Huy Gia Vuong, Ahmed M.A. Altibi, Uyen N.P. Duong, Hanh T.T. Ngo, Thong Quang Pham, Aden Ka-Yin Chan, Chul-Kee Park, Kar- Ming Fung, Lewis Hassell 
Critical Reviews in Oncology / Hematology 
Volume 120, Pages 1-9 (December 2017)
DOI: /j.critrevonc
Copyright © 2017 Elsevier B.V. Terms and Conditions

2. Fig. 1 Flowchart of the study.
Abbreviations: WoS, Web of Science; VHL, Virtual Health Library.
Critical Reviews in Oncology / Hematology  , 1-9DOI: ( /j.critrevonc )
Copyright © 2017 Elsevier B.V. Terms and Conditions

3. Fig. 2
Prognostic impact of TERT promoter mutations on overall survival (A) and progression-free survival (B) of gliomas.
Critical Reviews in Oncology / Hematology  , 1-9DOI: ( /j.critrevonc )
Copyright © 2017 Elsevier B.V. Terms and Conditions

4. Fig. 3
Prognostic impact of TERT promoter mutations on overall survival of IDH-wild type (A) and IDH-mutated WHO grade II/III gliomas.
Critical Reviews in Oncology / Hematology  , 1-9DOI: ( /j.critrevonc )
Copyright © 2017 Elsevier B.V. Terms and Conditions

5. Fig. 4
Aggregate data of median OS (months) of WHO grade II/III gliomas in the included studies.
Critical Reviews in Oncology / Hematology  , 1-9DOI: ( /j.critrevonc )
Copyright © 2017 Elsevier B.V. Terms and Conditions